Ocular CSO sells 1,897 shares at $10.78 each
OCULAR THERAPEUTIX, INC (OCUL) insider Sanjay Nayak, Chief Strategy Officer, reported a sale of 1,897 shares of Common Stock on 2026-08-24 at a weighted average price of $10.78 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
OCULAR THERAPEUTIX, INC (OCUL) insider Sanjay Nayak, Chief Strategy Officer, reported a sale of 1,897 shares of Common Stock on 2026-08-24 at a weighted average price of $10.78 per share. The shares were sold pursuant to a durable automatic Rule 10b5-1 sell-to-cover instruction to satisfy tax withholding on RSUs vesting on 2026-08-22 and are described as non-discretionary. Following this transaction, Nayak directly holds 326,898 shares of OCUL common stock.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2 | 1,897 | $10.78 | $20K |
Footnotes (2)
- F1. Represents shares of common stock of Ocular Therapeutix, Inc. (the "Corporation") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on August 22, 2026. The sales do not represent a discretionary trade by the reporting person.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.6425 to $10.8990, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
Key Figures
Key Terms
durable automatic sale instruction regulatory
sell-to-cover election financial
tax withholding obligations financial
restricted stock units financial
weighted average price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transaction did OCUL insider Sanjay Nayak report on this Form 4?
Was the OCUL insider sale by Sanjay Nayak a discretionary trade?
Is Sanjay Nayak’s OCUL trade covered by a Rule 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.